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caused no effect. Scatchard analysis of [3H]CORTI surfaceGlucocorticoid modulates Na1/H1 exchange activity in vascular
binding to VSMCs showed a single class of CORTI bindingsmooth muscle cells by nongenomic and genomic mechanisms.
sites with a Bmax of 876.2 fmol per mg of cell protein and a KdBackground. In vascular smooth muscle cells (VSMCs),
of 12.2 nmol/L. RU38486 also inhibited [3H]CORTI surfaceNa1/H1 exchange (NHE) plays an important role in intracellu-
binding to VSMCs.lar pH (pHi) regulation. The genomic effect of glucocorticoid
Conclusions. In VSMCs, NHE activity is stimulated by(GC) on NHE activity has been suggested in VSMCs. However,
short-term exposure to CORTI, but is inhibited by long-termthe nongenomic and genomic effects of GC on NHE activity
exposure to CORTI. The short-term stimulatory effect ofand the underlying intracellular signaling mechanisms have not
CORTI on NHE activity is independent of gene transcriptionyet been demonstrated in VSMCs. Also, it is not known
and protein synthesis, is mediated through the CORTI surfacewhether there are specific surface-binding sites of GC to the
receptor, and occurs through a microtubule-dependent process.plasma membrane of VSMCs.
The long-term inhibitory effect of CORTI on NHE activityMethods. The effects of short (3 h)- and long (24 h)-term
requires gene transcription and protein synthesis and occursexposure to corticosterone (CORTI) on NHE activity were
only through the cytosolic GR. The short- and long-term effectsstudied in cultured rat aortic VSMCs by using pHi measurement
of CORTI on NHE activity occur via PKC activation. There-with the pH-sensitive fluorescent dye 2979-bis(carboxyethyl)-
fore, CORTI differentially modulates NHE activity in VSMCs5(6)-carboxyfluorescein. The NHE activity was calculated from
by nongenomic and genomic mechanisms.the initial rate of Na1-dependent pHi recovery after the acid
load.
Results. Short-term exposure of VSMCs to CORTI (1026
mol/L) increased NHE activity, whereas long-term exposure Na1/H1 exchange (NHE) is a plasma membrane trans-to CORTI decreased it. The inhibitors of gene transcription
port protein found in a broad range of biological systems,(actinomycin D) and of protein synthesis (cycloheximide) did
including vascular smooth muscle cells (VSMCs) [re-not affect the short-term effect of CORTI on NHE activity,
but inhibited the long-term effect of CORTI on NHE activity. viewed in 1, 2]. In VSMCs, the entry of Na1 into cells
The cytosolic GC receptor (GR) antagonist (RU38486) inhib- in exchange for an intracellular H1 is the main effect
ited both the short- and long-term effects of CORTI on NHE of NHE, which therefore is involved in the control ofactivity, but the cytosolic mineralocorticoid receptor antagonist
intracellular pH (pHi), cell volume regulation, and initia-(spironolactone) did not influence either the short- or long-
tion of cell growth and proliferation [3–6].term CORTI effects. Two protein kinase C (PKC) inhibitors
(staurosporine A and calphostin C) and PKC down-regulation Glucocorticoids (GCs) play a fundamental role in the
[24-h pre-exposure to phorbol 12-myristate 13-acetate (PMA)] control of homeostasis, growth, and differentiation in
inhibited both short- and long-term CORTI effects. Exposure VSMCs [7–11]. Long-term exposure of VSMCs to GCsto PMA for three hours mimicked the short-term CORTI ef-
inhibits cell growth [7–9], whereas brief exposure to GCsfect. The short-term CORTI effect was inhibited by the dis-
stimulates it [9]. These reports raise the possibility thatruptor of microtubule (colchicine), but not by the disruptor of
filamentous-actin (cytochalasin B). The long-term exposure to GCs affect NHE activity in VSMCs.
CORTI decreased NHE (NHE-1) mRNA levels to 0.65 times It is generally accepted that the delayed and slow ac-
the control level, whereas the short-term exposure to CORTI tions (in hours or days) of GCs are mediated via the
classic genomic mechanism, which involves the activa-
tion of its high-affinity cytosolic receptor and then theKey words: corticosterone, Na1/H1 exchanger, intracellular pH regula-
tion, cell growth, glucocorticoid surface receptor, protein kinase C. translocation of GCs-receptor complex to the cell nu-
cleus. The activated GCs-receptor complex binds to spe-Received for publication August 24, 1999
cific DNA sequences, termed GC response elements,and in revised form December 17, 1999
Accepted for publication January 20, 2000 resulting in positive or negative modulation of gene tran-
scription [reviewed in 12, 13]. Berk et al reported thatÓ 2000 by the International Society of Nephrology
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hydrocortisone stimulates NHE activity of VSMCs after mechanisms for the nongenomic and genomic CORTI
effects. We also determined whether there are specifica latency of at least four hours, presumably by the classic
genomic pathway of the steroid action [8]. However, surface binding sites of CORTI to the plasma membrane
of VSMCs.they have not yet determined whether the stimulatory
effect of hydrocortisone on NHE activity occurs via cyto-
solic GC receptor (CGR) and/or mineralocorticoid re-
METHODS
ceptor (MR) and is associated with increased NHE
Culture of rat VSMCsmRNA. Also, the intracellular signaling mechanisms for
the genomic effect of hydrocortisone on NHE activity Primary cultures of rat VSMCs were isolated from
thoracic aortae of male Sprague-Dawley rats (200 toare unclear.
Besides these classic genomic mechanisms, it is now 250 g) by the treatment with collagenase, as described
previously in our laboratory [10, 11]. Briefly, the cellspossible to define the characteristics of any steroid action
that represents a nongenomic effect [reviewed in 12, 14]. were cultured in Eagle’s minimum essential medium
(MEM) supplemented with 10% fetal bovine serumThey are instantaneous or with a very short lag period
and are insensitive to RNA and protein synthesis inhibi- (FBS), 26.1 mmol/L NaHCO3, 100 U/mL penicillin, and
100 mg/mL streptomycin in a 5% CO2 incubator at 378C.tors. They are direct steroid actions, not mediated through
nuclear receptor occupancy. There is increasing evidence After reaching confluence, VSMCs were passaged through
trypsin/ethylenediaminetetraacetic acid (EDTA) andfor rapid nongenomic steroid actions, including neural
effects after local application of steroids and fast effects seeded at a 1:3 ratio in 100 mm culture dishes (Becton
Dickinson, Lincoln Park, NJ, USA). Experiments wereof steroids on the g-aminobutyric acid A receptor, on
luteinizing hormone-releasing peptide secretion, on do- performed with VSMCs, which were grown to confluence
after 4 to 10 passages.pamine release, on oocyte maturation, and on the acro-
some reaction in spermatozoa [14]. In our laboratory,
Measurements of pHi in VSMCswe have demonstrated that exposure of VSMCs to aldo-
sterone for three hours activates NHE via a nongenomic For pHi measurements, cells were plated on 35 mm
Petri dishes containing a glass coverslip bottom (MatTec,mechanism and that the nongenomic stimulatory effect
of aldosterone on NHE activity occurs through protein Ashland, MA, USA) and were used two to seven days
later. Cells were incubated in FBS-free MEM for 48 hourskinase C (PKC) activation and both microtubule- and
filamentous actin-dependent processes [6]. However, it before use. The pHi was continuously measured using the
pH-sensitive fluorescent dye 2979-bis(carboxyethyl)-5(6)-has not yet been established whether GCs actually have
nongenomic effects on NHE activity in VSMCs. Further- carboxyfluorescein acetoxymethyl ester (BCECF-AM)
according to the methods described by Berk et al [22, 23]more, little is known about the intracellular signaling
mechanisms for the nongenomic effect of GCs on NHE and as modified in this laboratory [6]. Prior to each
experiment, the cells grown to confluence were incu-activity in VSMCs.
There have now been numerous reports of steroid- bated for 30 minutes in FBS-free MEM containing
BCECF-AM (2 mmol/L) at 378C. The Petri dish was thenbinding sites to the plasma membranes of many tissues
[15–20], including kidney [15], liver [16], and neural tis- placed on the stage of an inverted epifluorescence micro-
scope (IMT-2; Olympus, Tokyo, Japan) and was thensue [18]. The identification of the steroid-binding sites
to the plasma membranes supports the hypothesis of continuously perfused with HEPES-buffered solutions
(described later in this article) by gravity. A water jacketnongenomic steroid action involving plasma membrane
surface receptors distinct from the classic cytosolic ste- was used to maintain temperature in the dish at 378C.
A single-cell measurement of pHi was performed usingroid receptors. However, it is not known whether there
are specific surface binding sites of GCs to the plasma a microscopic fluorometer (OSP-3; Olympus) as de-
scribed previously in our laboratory [6]. Measurementsmembrane of vascular tissue.
In previous studies, dexamethasone and hydrocorti- were made at 3100 magnification, and the diameter of
the beam of light focused on the single VSMC was ap-sone were used as GCs to examine the effects of GCs
on NHE activity and growth response in cultured proximately 7.5 mm. The light source was a 75 W xenon
lamp. The fluorescent dye was excited alternatively atVSMCs from rat and bovine aortae [7–9]. However, they
are not endogenous GCs in rats. In the present study, 440 and 490 nm by spinning the sector mirror at 300
r.p.m. and was measured at a wavelength of 530 nm.we chose corticosterone (CORTI) as a GC, since this
steroid is the natural and possibly sole GC in rats [21]. Because in this apparatus it takes 10 ms to obtain one
fluorescence ratio (I490/I440), the single VSMC was exposedTherefore, the present study used cultured VSMCs
from rat aortae to determine whether there are nongeno- to light for one second to obtain one mean I490/I440. We
used only VSMCs that had at least a 20-fold greatermic and genomic effects of CORTI on NHE activity
in VSMCs, and to determine the intracellular signaling fluorescence intensity than that of the background. Cali-
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bration of the BCECF excitation ratio for each experi- fragment (nucleotides 478 to 1850) of the rat NHE-1
cDNA (a generous gift from Dr. John Orlowski, McGillment was determined using the K1/nigericin technique
as described previously [6, 24]. University, Montreal, Canada) [28]. The filters were then
washed twice for 10 minutes at room temperature in 2 3The NHE activity of VSMCs was assayed as the initial
rate of Na1-dependent pHi increase (dpHi/dt) after acid SSC and 0.1% sodium dodecyl sulfate (SDS) followed
by a 10-minute wash at 458C in 0.1 3 SSC and 0.1%load using nigericin, a K1/H1 ionophore, in the absence
of CO2/HCO32 [6, 25, 26]. The composition of solutions SDS. Autoradiography was performed at 2708C and
quantitated by densitometric scanning (Image Analyzerused for the assay was as follows: (1) for HEPES-buf-
fered Na1 solution, 130 mmol/L NaCl, 5 mmol/L KCl, TIF-64; Immunomedica, Tokyo, Japan). The filter mem-
branes were also hybridized with an [a-32P]-dCTP–1.5 mmol/L MgCl2, 1 mmol/L CaCl2, and 30 mmol/L
HEPES; and (2) for Na1-free solution, Na1 was isosmoti- labeled rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) probe. The NHE-1 mRNA area was stan-cally replaced with N-methyl-D-glucamine (NMDG).
All solutions were adjusted to a pH of 7.4 at 378C. Once dardized for each lane in the GAPDH area to control
for variability in RNA loading.a stable fluorescence signal was reached, Na1 was re-
moved by replacing NMDG. With removal of Na1, the
[1, 2-3H(N)]-CORTI ([3H]CORTI) surface receptorpHi decreased, and when Na1 was readded, there was
binding to VSMCsrapid recovery of pHi to baseline levels. The dpHi/dt was
calculated from a line drawn tangential to the initial 30- The specific binding of [3H]CORTI to surface recep-
tors was determined by using intact VSMCs and wassecond deflection after the return of Na1 to the perfusate.
Intracellular buffering capacity was determined from performed in binding buffer, which consisted of 140
mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L CaCl2, 0.5the pHi response to the removal of NH3/NH41 using the
following formula: intracellular buffering capacity (bI) 5 mmol/L MgCl2, 5 mmol/L glucose, 1 mmol/L Na2HPO4,
10 mmol/L Tris/HCl, and 0.2% bovine serum albuminD[NH41]i/DpHi, where [NH41]i is the intracellular con-
centration just before NH3/NH41 removal, calculated as (BSA), pH 7.4. All steps were carried out at 48C to
ensure that internalization of the receptor-ligand com-[NH41]i 5 [NH41]o 3 10(7.4-pHi), and DpHi is the pHi change
on removal of NH41 [6, 27]. A change in dpHi/dt is plex would not occur. The experiments used confluent
monolayers of VSMCs grown in 35 mm culture dishesinterpreted to reflect a difference in NHE activity when
intracellular buffering capacities in two conditions are (Becton Dickinson). At the beginning of each experi-
ment, the culture medium was aspirated from the dishes,similar.
and cells were then washed twice with 2 mL ice-cold
RNA isolation and Northern blot analysis binding buffer. Equilibrium binding studies were per-
formed at 48C for 60 minutes in binding buffer containingVascular smooth muscle cells were cultured and grown
in 100 mm culture dishes (Becton Dickinson). Confluent various concentrations of [3H]CORTI from 8 3 10211 to
1027 mol/L. Preliminary experiments demonstrated thatVSMCs were placed in serum-free MEM for 48 hours
and were then exposed to CORTI (1026 mol/L) for the under these conditions, equilibrium was reached. The
incubation volume was 0.9 mL. At the end of the incuba-next 24 hours. Thereafter, total RNA was isolated using
a single-step guanidine thiocyanate method as reported tion, the reaction mixture was aspirated, and the cells
were then rinsed four times with 2 mL ice-cold bindingpreviously [10, 11]. In brief, VSMCs were lyzed using
ISOGENe (Nippon Gene, Tokyo, Japan), which con- buffer. The attached cells were then dissolved with 1.5
mL of 0.1% SDS and 0.1 N NaOH. Radioactivity intained phenol and guanidine isothiocyanate. The lysate
was extracted with chloroform/isopropanol and was the dissolved cells was counted by a liquid scintilation
counter (Aloka LSC-671, Tokyo, Japan). A portion ofwashed with 75% ethanol. Poly (A)1 RNA was purified
using oligo(dT)-latex column (Takara, Tokyo, Japan), the dissolved cells was used for determining the protein
content [29]. Nonspecific binding was determined in theas described previously [6]. Equal amounts of Poly (A)1
RNA (5 mg/lane) were size fractionated on 1% denatur- presence of 1025 mol/L unlabeled CORTI. Receptor den-
sity (Bmax values) and dissociation constant (Kd) foring agarose-formaldehyde gels and capillary blotted onto
nylon membrane filters (Hybond N; Amersham, Arling- [3H]CORTI were calculated from Scatchard plots [30]. In
addition, a trypsin-dependent loss of [3H]CORTI surfaceton Heights, IL, USA) in 20 3 standard saline citrate
(SSC; 1 3 SSC contains 0.15 mol/L NaCl and 0.0015 binding was studied following exposure of the VSMCs
to 0.25% trypsin for 30 minutes at 378C. Thereafter,mol/L sodium citrate, pH 7.0). The filters were prehy-
bridized for 30 minutes at 688C before hybridization us- VSMCs were incubated with 4 3 1029 mol/L [3H]CORTI
in the absence or presence of 1025 mol/L unlabeleding Quick-Hybe (Stratagene, La Jolla, CA, USA), and
were then hybridized for one hour at 688C in the same CORTI at 48C for 60 minutes. After washing the binding
buffer, the cells were rinsed with the ice-cold bindingsolution with 106 cpm/mL of [a-32P]-dCTP random
primer-labeled probes. The NHE probe was a Pst I-Pst I buffer to remove the unbound radioactive ligand. The
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count of surface radioligand was then measured after
solubilizing the cells as described previously in this arti-
cle. Specific binding was calculated as the difference be-
tween total binding and nonspecific binding. To further
characterize the CORTI surface receptors in VSMCs,
monolayers of VSMCs were also incubated with the fixed
[3H]CORTI (4 3 1029 mol/L) and increasing concentra-
tions of unlabeled CORTI or RU38486 (RU) from 10211
to 1025 mol/L at 48C for 60 minutes. After washing the
binding buffer, the cells were rinsed with the ice-cold
binding buffer to remove the unbound radioactive li-
gand. The count of surface radioligand was then mea-
sured after solubilizing the cells, as described previously
in this article. All binding experiments were performed
in triplicate and were repeated at least twice with similar
results.
Fig. 1. Effects of corticosterone (CORTI; 1026 mol/L) on baseline in-
Materials tracellular pH (pHi) in vascular smooth muscle cells (VSMCs). VSMCs
were exposed to control Eagle’s minimum essential medium (MEM;All chemicals were obtained from Sigma Chemical
h) or CORTI-supplemented MEM ( ) for 3 or 24 hours before the
Co. (St. Louis, MO, USA) unless noted as follows. MEM, measurement of pHi. pHi measurements were carried out in the nominal
absence of CO2/HCO32. Data are expressed as means 6 SE. *P ,penicillin, streptomycin, and FBS were from Flow
0.01; **P , 0.001 compared with control. The numerals in parenthesesLaboratories (Irvine, Scotland, UK). Ethylisopropylami- indicate number of experiments.
loride (EIPA) was from Research Biochemicals Incor-
porated (Natick, MA, USA). HEPES was from Dojindo
(Kumamoto, Japan). [a-32P]-dCTP was from Amersham.
RESULTS[3H]CORTI was from New England Nuclear (Boston,
MA, USA), and BCECF-AM was from Molecular Effect of CORTI on pHi in VSMCs
Probes Inc. (Eugene, OR, USA). RU 38486 (RU) was a We first examined the effects of CORTI on baseline
generous gift from Roussel Uclaf (Romainville, France). pHi in VSMCs. VSMCs were placed in serum-free MEM
CORTI was dissolved in ethanol as a 1022 mol/L stock for 48 hours before the addition of the hormone and
solution and then diluted to final concentrations of 10211 were then exposed to CORTI (1026 mol/L) for 3 hours
to 1025 mol/L. RU was also dissolved in ethanol as a (short-term exposure) or 24 hours (long-term exposure).
1021 mol/L stock solution and then diluted to final con- The results are illustrated in Figure 1. After short-term
centrations of 10211 to 1025 mol/L. Colchicine (COL) exposure of VSMCs to CORTI, the baseline pHi (7.12 6
was dissolved in ethanol at 0.1% final concentration. 0.02, N 5 8, P , 0.01) was significantly greater than that
Cycloheximide (CHX) was prepared as a 4 mg/mL stock in cells exposed to control MEM (7.04 6 0.03, N 5 8).
solution in distilled water and diluted to a final concen- In contrast, after continuous exposure to CORTI for 24
tration of 20 mg/mL. Actinomycin D (ACD) was pre- hours, the basal pHi of VSMCs (6.91 6 0.04, N 5 8, P ,
pared as a 1 mg/mL stock solution in distilled water and 0.001) was significantly decreased when compared with
diluted to a final concentration of 4 mg/mL. EIPA was that in cells exposed to control MEM (7.06 6 0.01, N 5
dissolved in methanol at 1021 mol/L and diluted to a 8). Thus, the short-term exposure to CORTI alkalinized
final concentration of 100 mmol/L. Spironolactone (SPR), VSMCs, whereas the long-term exposure to CORTI
staurosporine A (ST), calphostin C (CAL), phorbol 12- acidified them.
myristate 13-acetate (PMA), and cytochalasin B (CYTO)
Effect of CORTI on NHE activitywere dissolved in dimethyl sulfoxide at 0.1% final con-
centrations. Equivalent concentrations of vehicle were Since the NHE is an important mechanism for the
added as a control for individual protocols. maintenance and regulation of pHi in VSMCs [4], we
next examined whether the CORTI-induced changes in
Statistical analysis pHi depend on changes in NHE activity. For this purpose,
Results are expressed as mean 6 SEM. Comparisons VSMCs were placed in serum-free MEM for 48 hours
were performed by Student’s t-test and one-way analysis before the addition of the hormone and were then ex-
of variance (ANOVA) in combination with Fisher’s pro- posed to CORTI (1026 mol/L) for 3 or 24 hours. Cells
tected least significant difference, as needed. P values were first bathed in the HEPES-buffered Na1 solution
(130 mmol/L Na). The solution was then changed to theof , 0.05 were considered significant.
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Fig. 2. Typical fluorescent tracing of pHi showing Na1-dependent pHi recovery (dpHi /dt) in VSMCs exposed to CORTI (1026 mol/L) for (A) 3
or (B) 24 hours in the absence or presence of 100 mmol/L EIPA. pHi measurements were carried out in the nominal absence of CO2/HCO32.
Symbols are: (s) control; (d) CORTI; (h) control 1 EIPA; (j) CORTI 1 EIPA.
Na1-free solution (0 mmol/L Na) containing 10 mmol/L
nigericin for four minutes, which caused pHi to decrease
to ,5.9 to 6.1. Nigericin was then removed by resus-
pending the cells in the Na1-free solution containing
1% (wt/vol) BSA (which binds the ionophore) for two
minutes. Cells were then bathed in the Na1-free solution
for one minute. Thereafter, a subsequent addition of
Na1 to the extracellular solution caused a rapid increase
in pHi, as shown in Figure 2; the rise was more rapid
and greater in VSMCs exposed to CORTI (0.84 6 0.06
pH/min, N 5 8, P , 0.01) for three hours than in cells
exposed to control MEM (0.64 6 0.05 pH/min, N 5 8).
In sharp contrast, the Na1-dependent pHi increase after
acid load was inversely slower and smaller in VSMCs
Fig. 3. Time course of Na1-dependent pHi recovery (dpHi /dt) inducedexposed to CORTI (0.51 6 0.03 pH/min, N 5 8, P , by CORTI in VSMCs. VSMCs were exposed to control MEM or CORTI
(1026 mol/L)-supplemented MEM for various terms before the measure-0.01) for 24 hours than in cells exposed to control MEM
ment of dpHi/dt after a nigericin-induced intracellular acidosis. pHi(0.70 6 0.04 pH/min, N 5 8). The Na1-dependent pHi measurements were carried out in the nominal absence of CO2/HCO32.recoveries after acid load in cells treated with both con- Data are expressed as means 6 SE of eight separate experiments. *P ,
0.005; **P , 0.001 compared with control.trol MEM and with CORTI-supplemented MEM for 3
and 24 hours were completely inhibited by 100 mmol/L
EIPA, a specific NHE inhibitor (Fig. 2). On the other
hand, there were no significant differences of intrinsic
treated with CORTI for 3 hours, but was inhibited inbuffering capacity at pHi of 6.1 between control and
VSMCs treated with CORTI for 24 hours.CORTI-treated VSMCs at 3 hours [control, 19.6 6 0.7
We next examined the time-dependent alterations in(mmol/L)/H1 · pH, N 5 5; CORTI, 18.8 6 0.9 (mmol/
the NHE activity induced by CORTI (1026 mol/L). TheL)/H1 · pH, N 5 5] and 24 hours [control, 19.5 6 0.8
results are shown in Figure 3. Upon the addition of(mmol/L)/H1 · pH, N 5 5; CORTI, 19.2 6 0.7 (mmol/
CORTI to VSMCs, the dpHi/dt after acid load rapidlyL)/H1 · pH, N 5 5]. Therefore, the Na1-dependent pHi
increased to 1.3 times the control by as early as threerecovery after an acid load was dependent on the NHE
activity, and the NHE activity was stimulated in VSMCs hours. However, the CORTI-induced increase in dpHi/dt
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was not sustained. A significant difference of the dpHi/dt
in cells treated with CORTI for 12 hours was not ob-
served. Further long-term exposure of VSMCs to
CORTI for 24 hours inversely caused a significant de-
crease in dpHi/dt to 0.7 times the control level. Thus, the
short-term exposure to CORTI stimulated NHE activity,
whereas the long-term exposure to CORTI inhibited it.
Dose-dependent effect of CORTI on NHE activity
We next examined the dose-dependent effects of
CORTI on NHE activity. VSMCs were placed in serum-
free MEM for 48 hours and were then exposed to CORTI
at various concentrations for 3 or 24 hours. As shown
in Figure 4, both a CORTI-induced increase and de-
crease in NHE activities were dose-dependent. Signifi-
cant effects of CORTI on NHE activity were observed
at 1027 to 1026 mol/L. In rats, plasma concentrations of
CORTI are in the range of 1027 to 1026 mol/L [31].
Therefore, CORTI at physiological concentrations af-
fects NHE activity. In the following experiments, we
focused on the mechanisms for the short- and long-term
effects of CORTI on NHE activity.
Effects of CHX and ACD on CORTI-induced
changes in NHE activity
To determine whether protein synthesis and gene tran-
scription are required for the CORTI-induced changes
in NHE activity, VSMCs were incubated with CHX, an
inhibitor of protein synthesis, or ACD, an inhibitor of
gene transcription. For these experiments, VSMCs were
placed in serum-free MEM for 48 hours and were then
exposed to MEM treated with CHX (20 mg/mL) or ACD
(4 mg/mL) plus CORTI (1026 mol/L) for 3 or 24 hours.
This concentration of CHX (20 mg/mL) inhibited protein
synthesis by 95%, as determined by [3H]leucine incorpo-
ration [10], and the results are shown in Figure 5A (for
CHX-treated VSMCs) and Figure 5B (for ACD-treated
VSMCs). CHX or ACD alone had no effect on NHE
activity. Either CHX or ACD did not influence the short-
term stimulatory effect of CORTI on NHE activity,
whereas both of them completely prevented the long- Fig. 4. Dose-dependent effects of CORTI on NHE activity in VSMCs.
VSMCs were exposed to CORTI at various concentrations for (A) 3term inhibitory effect of CORTI on NHE activity.
or (B) 24 hours. pHi measurements were carried out in the nominal
absence of CO2/HCO32. Data are expressed as the percentage of dpHi/dtEffects of RU and SPR on CORTI-induced changes
compared with those observed in VSMCs exposed to control MEM.
in NHE activity The number of experiments done on VSMCs treated with CORTI for
3 and 24 hours is eight and five, respectively. *P , 0.05; **P , 0.005;To examine whether the effects of CORTI on NHE
†P , 0.001 compared with control value.
activity occurs via cytosolic GR and/or MR, VSMCs were
placed in serum-free MEM for 48 hours and were then
exposed to the cytosolic GR antagonist RU (1025 mol/L) NHE activity, whereas SPR did not affect either the
or the cytosolic MR antagonist SPR (1024 mol/L), plus short-term or the long-term CORTI effects.
CORTI (1026 mol/L) for 3 or 24 hours. The results were
Effect of PKC pathway modulation onshown in Figure 6A (for RU-treated VSMCs) and Figure
CORTI-induced changes in NHE activity6B (for SPR-treated VSMCs). RU or SPR alone caused
no effects on NHE activity. RU completely inhibited Protein kinase C has been shown to play an important
role in the regulation of NHE activity in many tissuesboth the short- and the long-term effects of CORTI on
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Fig. 5. Effects of inhibitors of protein synthesis, cycloheximide (CHX), or gene transcription, actinomycin D (ACD), on CORTI-induced changes
in NHE activity in VSMCs. pHi measurements were carried out in the nominal absence of CO2/HCO32. (A) VSMCs were exposed to control
MEM or CORTI (1026 mol/L)-supplemented MEM for 3 or 24 hours in the absence or presence of CHX (20 mg/mL). Data are expressed as the
percentage of dpHi/dt compared with those observed in CORTI-untreated VSMCs without CHX (control). The number of experiments done on
VSMCs treated with CHX for 3 and 24 hours is six and eight, respectively. (B) VSMCs were exposed to control MEM or CORTI (1026 mol/L)-
supplemented MEM for 3 or 24 hours in the absence or presence of ACD (4 mg/mL). Data are expressed as the percentage of dpHi/dt compared
with those observed in CORTI-untreated VSMCs without ACD (control). The number of experiments done on VSMCs treated with ACD for 3
and 24 hours is six and eight, respectively.
[1, 32], including VSMCs [6, 23, 33, 34]. Therefore, we 1027 mol/L), plus CORTI (1026 mol/L) for 3 or 24 hours.
The results for ST-treated VSMCs are shown in Figureexamined whether PKC activation is responsible for the
CORTI-induced changes in NHE activity. For this pur- 7A and for CAL-treated VSMCs in Figure 7B. ST or
CAL alone had no effect on NHE activity. On the otherpose, VSMCs were placed in serum-free MEM for 48
hours and were then exposed to MEM treated with one hand, ST and CAL completely inhibited the short-term
stimulatory effect of CORTI on NHE activity and com-of two PKC inhibitors, ST (1027 mol/L) or CAL (5 3
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Fig. 6. Effects of the glucocorticoid receptor antagonist RU 38486 (RU) or the mineralocorticoid receptor antagonist spironolactone (SPR) on
CORTI-induced changes in NHE activity in VSMCs. pHi measurements were carried out in the nominal absence of CO2/HCO32. (A) VSMCs
were exposed to control MEM or CORTI (1026 mol/L)-supplemented MEM for 3 or 24 hours in the absence or presence of RU (1025 mol/L).
Data are expressed as the percentage of dpHi/dt compared with those observed in CORTI-untreated VSMCs without RU (control). The number
of experiments done on VSMCs treated with RU for 3 and 24 hours is six and eight, respectively. (B) VSMCs were exposed to control MEM or
CORTI (1026 mol/L)-supplemented MEM for 3 or 24 hours in the absence or presence of SPR (1024 mol/L). Data are expressed as the percentage
of dpHi/dt compared with those observed in CORTI-untreated VSMCs without SPR (control). The number of experiments done on VSMCs
treated with SPR for 3 and 24 hours is six and eight, respectively.
pletely prevented the long-term inhibitory effect of VSMCs [34]. The VSMCs were then exposed to either
control MEM or CORTI-supplemented MEM for 3 orCORTI on NHE activity. The role of PKC was further
examined in PKC-depleted cells. For this experiment, 24 hours in the presence of PMA. The results are shown
in Figure 7C. Pre-exposure of VSMCs to PMA aloneVSMCs were placed in serum-free MEM for 48 hours
and were then pre-exposed to PMA (a specific activator had no effect on NHE activity. On the other hand, it
completely inhibited both short- and long-term effectsof PKC; 1027 mol/L) for 24 hours. This treatment has
been reported to down-regulate PKC activity in cultured of CORTI on NHE activity. We next examined whether
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Fig. 7. Effects of protein kinase C (PKC) inhibitors or PKC down-regulation on CORTI-induced changes in NHE activity in VSMCs. pHi
measurements were carried out in the nominal absence of CO2/HCO32. (A) VSMCs were exposed to control MEM or CORTI (1026 mol/L)-
supplemented MEM for 3 or 24 hours in the absence or presence of staurosporine A (ST). Data are expressed as the percentage of dpHi/dt
compared with those observed in CORTI-untreated VSMCs without ST (control). The number of experiments done on ST-treated VSMCs for 3
and 24 hours is eight. (B) VSMCs were exposed to control MEM or CORTI (1026 mol/L)-supplemented MEM for 3 or 24 hours in the absence
or presence of calphostin C (CAL; 5 3 1027 mol/L). Data are expressed as the percentage of dpHi/dt compared with those observed in CORTI-
untreated VSMCs without CAL (control). The number of experiments done on CAL-treated VSMCs for 3 and 24 hours is eight. (C) VSMCs
were exposed to control MEM or CORTI (1026 mol/L)-supplemented MEM for 3 or 24 hours with or without 24-hour pre-exposure of phorbol
12-myristate 13-acetate (PMA; 1027 mol/L). Data are expressed as the percentage of dpHi/dt compared with those observed in CORTI-untreated
VSMCs without PMA (control). The number of experiments done on PMA-treated VSMCs for 3 and 24 hours is five. (D) VSMCs were exposed
to control MEM or PMA (1027 mol/L)-supplemented MEM for three hours. Data are expressed as the percentage of dpHi/dt compared with those
observed in PMA-untreated VSMCs (control). The number of experiments done on PMA-treated VSMCs is four.
exposure of VSMCs to PMA for three hours actually then exposed to MEM treated with either COL (1024
mol/L) or CYTO (1024 mol/L), plus CORTI (1026 mol/L)increases NHE activity. As shown in Figure 7D, treat-
ment of VSMCs with PMA (1027 mol/L) for three hours for three hours. The results for COL-treated VSMCs are
shown in Fig. 8A and for CYTO-treated VSMCs in Fig.caused NHE activity to increase to 1.4 times the control
level. 8B. COL or CYTO alone had no influence on NHE
activity. COL completely inhibited the short-term stimu-
Role of cytoskeletal elements in mediating latory effect of CORTI on NHE activity, but CYTO had
CORTI-induced increase in NHE activity no effect.
It has been reported that the interactions between
Effect of CORTI on NHE mRNA levels in VSMCsthe cytoskeleton and the plasma membrane regulate the
activity of many ion channels and transport proteins, These experiments suggest that transcription and
translation are involved only in the long-term effect ofincluding NHE [6, 35, 36]. To determine whether the
cytoskeleton is involved in the short-term effect of CORTI on NHE activity. Therefore, we examined the
short- and long-term effects of CORTI on NHE (NHE-1)CORTI on NHE activity, VSMCs were incubated with
COL, a disruptor of microtubule, or CYTO, a disruptor mRNA levels in VSMCs. Representative Northern blots
are shown in Figure 9. The NHE-1 cDNA probe hybrid-of filamentous actin (F-actin). For this purpose, VSMCs
were placed in serum-free MEM for 48 hours and were ized to a single band of 4.8 to 5.0 kb, as previously
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Fig. 8. Effects of cytoskeleton disruptors, colchicine (COL), or cytochalasin B (CYTO) on the short-term CORTI-induced increase in NHE
activity in VSMCs. VSMCs were exposed to control MEM or CORTI (1026 mol/L)-supplemented MEM for three hours in the absence or presence
of COL (1024 mol/L) or CYTO (1024 mol/L). pHi measurements were carried out in the nominal absence of CO2/HCO32. Data are expressed as
the percentage of dpHi/dt compared with those observed in CORTI-untreated VSMCs without COL or CYTO (control). The number of experiments
done on COL- and CYTO-treated VSMCs is five.
described for NHE-1 mRNA in cultured VSMCs [6]. respectively. Therefore, treatment with 0.25% trypsin
Upon addition of CORTI (1026 mol/L) to VSMCs for significantly inhibited [3H]CORTI-specific binding (con-
three hours, NHE-1 mRNA levels were not significantly trol cells, 3937.0 6 244.2 cpm, N 5 3; trypsin-treated
altered. On the other hand, when VSMCs were exposed cells, 763.6 6 172.0 cpm, N 5 3, P , 0.005). Figure 10B
to CORTI for 24 hours, NHE-1 mRNA levels decreased shows the surface receptor binding of [3H]CORTI with
to 0.65 times the control level. There was no significant unlabeled CORTI or RU to VSMCs. At 4 3 1029 mol/L
difference in GAPDH mRNA levels between the control [3H]CORTI, approximately 71% of the total counts were
and CORTI-treated VSMCs. bound, with nonspecific binding (binding in the presence
of 1 3 1025 mol/L nonradioactive CORTI) representing
[3H]CORTI surface receptor binding to VSMCs 29% of the total counts. The presence of unlabeled
Scatchard analysis of the binding data revealed a linear CORTI or RU displaced bound [3H]CORTI to VSMCs
plot demonstrating a single class of CORTI binding sites in a similar and competitive manner. The curve in RU-
with a Bmax of 876.2 fmol per mg of cell protein and a treated VSMCs was slightly shifted to right, as compared
Kd of 12.2 nmol/L (Fig. 10A). To determine whether with the curve in CORTI-treated VSMCs, indicating that
[3H]CORTI receptor binding was sensitive to trypsin, RU has a slightly lower affinity for [3H]CORTI surface
which removes surface receptors [37, 38], the effect of receptors than nonradioactive CORTI.
exposure to 0.25% trypsin on [3H]CORTI binding to
VSMCs was studied. In control VSMCs, at 4 3 1029
DISCUSSIONmol/L [3H]CORTI, the total and nonspecific (in the pres-
The present study was designed to determine whetherence of 1 3 1025 mol/L nonradioactive CORTI) counts
CORTI modulates NHE activity in VSMCs and to deter-were 9868.6 6 375.3 (N 5 3) and 5931.6 6 209.1 cpm
mine the mechanisms for CORTI-induced changes in(N 5 3), respectively. On the other hand, in trypsin-
NHE activity. Our data demonstrate that CORTI in-treated cells, the total and nonspecific counts were
1101.6 6 230.4 (N 5 3) and 338.0 6 59.4 cpm (N 5 3), creases VSMCs NHE activity as early as three hours.
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Fig. 9. Effects of CORTI on steady-state NHE (NHE-1) mRNA levels
in VSMCs. VSMCs were exposed to control MEM or CORTI (1026
mol/L)-supplemented MEM for 3 or 24 hours. Five micrograms of
poly (A)1 RNA from control and CORTI-treated VSMCs were size
fractionated by 1% agarose-formaldehyde gel electrophoresis, trans-
ferred to nylon membrane, and hybridized rat NHE-1 (upper panel)
and GAPDH (lower panel) cDNA probes. Data are representative of
five separate experiments that gave similar results.
However, this effect was not sustained. Twenty-four–
hour exposure to CORTI showed a significant decrease
Fig. 10. (A) Scatchard plot of [3H]CORTI surface receptor binding toin NHE activity. Both short- and long-term effects of
VSMCs. The experimental protocols were described in detail in theCORTI on NHE activity are dose dependent. Short-
Methods section. Each point represents mean of three separate experi-
term (3 hours) stimulatory effect of CORTI on NHE ments. (B) Influence of unlabeled CORTI (h) or RU (e) on the surface
binding of [3H]CORTI to VSMCs. The experimental protocols wereactivity occurs independently of gene transcription and
described in detail in the Methods section. Each point representsprotein synthesis, occurs through the CORTI surface
mean 6 SEM (N 5 3).
receptor, is mediated by microtubule-dependent process,
and is not accompanied by increased NHE-1 mRNA
levels. In sharp contrast, a long-term (24 hours) inhibi-
tory effect of CORTI on NHE activity requires gene activity was not affected by inhibitors of transcription
transcription and protein synthesis, occurs only through (ACD) or translation (CHX). Therefore, the short-term
the cytosolic GR, and is associated with decreased NHE- effect is related to a nongenomic effect. This is further
1 mRNA levels. Both short- and long-term effects of supported by the fact that short-term exposure to
CORTI on NHE activity are PKC dependent. This study CORTI did not increase NHE-1 mRNA levels (Fig. 9).
was the first to demonstrate dual modulation of NHE Recently, our laboratory reported that exposure of
activity by GC in VSMCs. VSMCs to aldosterone for three hours also activates
NHE through a nongenomic mechanism [6].
Short-term stimulation of NHE activity by CORTI Since the previously mentioned findings suggest that
the short-term CORTI effect is mediated through surfaceThe present study found that short-term exposure to
CORTI increased basal levels of pHi and that this in- receptors, we performed binding studies of [3H]CORTI
to surface receptors in VSMCs. Our results demonstratecrease in pHi is caused by NHE activation. Furthermore,
the short-term stimulatory effect of CORTI on NHE the presence of specific surface binding sites for CORTI
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in VSMCs. The Scatchard analysis indicates that completely inhibited the nongenomic stimulatory effect
of CORTI on NHE activity (Fig. 6A). Accordingly, RU[3H]CORTI binds to one type of binding site in VSMCs
(Fig. 10A). The Kd and Bmax values for the CORTI bind- could bind to the CORTI surface receptor in the plasma
membrane of VSMCs to inhibit the stimulatory effecting sites found in this work are similar to those in
[3H]CORTI binding to rat kidney plasma membrane [15] of CORTI on NHE activity. Similarly, Liu and Chen
reported that RU partially blocked the rapid inhibitoryand to rat liver plasma membrane [16], but are 10- and
8-fold greater than those in [3H]CORTI binding to bo- effect of CORTI on release of arginine vasopressin from
hypothalamic slices in rats [45]. It is suggested that therevine aortic cytosol, respectively [39]. Thus, we can de-
duce that the specific [3H]CORTI binding observed in is probably some homology between the membrane
binding site of CORTI and cytosolic GR, since RUthe present study is not to the cytosolic receptor for
several reasons. First, in the present experiments, the blocked not only the classic genomic actions at the cyto-
solic GR, but also nongenomic effects at the surfacebinding of [3H]CORTI was determined by use of intact
VSMCs at 48C. At this temperature, internalization/en- receptor of the plasma membrane.
We demonstrate that two dissimilar inhibitors of PKCdocytosis is effectively arrested, and ligand binding is
held to represent surface binding sites for many physio- activity (ST and CAL) or prior down-regulation of PKC
activity by 24-hour pre-exposure to PMA prevented thelogically important macromolecules that enter cells by
receptor-mediated endocytosis [40, 41]. Reported bind- short-term stimulatory effect of CORTI on NHE activ-
ity. We also found that short-term exposure of VSMCsing studies of vasoconstrictor peptide hormones (such
as arginine vasopressin, angiotensin II, and endothelin) to PMA mimicked the stimulatory effect of CORTI on
NHE activity. Taken together, our results are consistentto surface receptors of the plasma membrane have been
performed at 48C [37, 38, 41, 42]. Second, trypsin treat- with the notion that the short-term stimulatory effect
of CORTI on NHE activity is mediated through PKCment, which moves cell surface receptor [37, 38], de-
creased specific binding of [3H]CORTI to VSMCs by activation, although we have not yet determined whether
CORTI actually stimulates PKC activity in VSMCs. Sim-81%, indicating the protein nature of this binding site.
Andres et al also reported that specific CORTI binding ilar findings have been reported in VSMCs treated with
aldosterone for three hours [6] and PMA-treated innerto calf adrenal cortex plasma membrane was reduced by
more than 70% when membranes were pretreated with medullary collecting duct cells from rat kidneys [46].
There are several potential mechanisms to explain theproteases [17]. Third, the specific binding site determined
in VSMCs is different from the characterized binding of PKC-dependent NHE activation induced by CORTI.
One possibility is that PKC could phosphorylate the reg-corticosteroid-binding globulin to rat cell membrane
[43]. This binding was a little specific at 48C, and the ulatory protein of NHE or the NHE itself directly [23,
33, 47, 48] and subsequently activate NHE. In supportmaximal binding was obtained at 378C. The kinetic pa-
rameters were Kd of 0.84 mmol/L and a Bmax of 39 of this concept, Sardet et al first described in hamster
fibroblasts that the NHE is rapidly phosphorylated inpmol/mg protein. The values of Kd and Bmax are 70- and
50-fold greater than those obtained for the CORTI bind- response to various mitogens, and that this phosphoryla-
tion of the NHE is temporally correlated with its activa-ing sites in this work, respectively. Thus, the specific
[3H]CORTI binding to VSMCs is not due to a corticoste- tion [47]. That the magnitude of phosphorylation could
regulate the rate of NHE is also suggested by the findingroid-binding globulin. Taken together, our data suggest
that CORTI binds to the surface receptor of the plasma that vanadate, an inhibitor of phosphatases, activates
NHE in A431 cells [48]. Additional experiments supportmembrane in VSMCs to activate NHE and that trypsin
is a potent inhibitor of [3H]CORTI binding to plasma the hypothesis that PKC is one of the kinases responsible
for this phosphorylation in VSMCs [23, 49]. Grinsteinmembrane of VSMCs. The existence of a plasma mem-
brane receptor for steroid hormones has been exten- et al have shown in rat thymic lymphocytes that direct
PKC activation by PMA increases NHE activity by caus-sively reported in many tissues [15–20]. Further studies
are required to characterize the CORTI receptor in the ing an alkaline shift in the pHi dependence of the antiport
[50, 51]. Thus, it is also possible that the NHE activationplasma membrane of VSMCs.
RU has anti-GC activity and high binding affinity for could occur via a PKC-dependent alkaline shift in the
pHi responsiveness of an allosteric modifier site on thea cytosolic GR [44]. In bovine aortic cytosol, [3H]CORTI
bound mainly to the RU-blockable component [39]. On cytoplasmic surface of the cell membrane [51, 52].
As shown in Figure 8, COL, but not CYTO, inhibitsthe other hand, RU has a slightly lower affinity for
[3H]CORTI binding to the surface receptor of VSMCs the short-term stimulatory effect of CORTI on NHE
activity in VSMCs. These findings raise the possibilitythan unlabeled CORTI (Fig. 10B). Thus, the inhibitory
characteristic of RU on [3H]CORTI binding to the sur- that microtubule, but not F-actin, may regulate the exo-
cytic insertion of NHE protein into the plasma mem-face receptor of VSMCs in this study is strikingly distinct
from that of the bovine aortic cytosol. Moreover, RU brane in CORTI-treated VSMCs. Similarly, Bloch et al
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reported that angiotensin II stimulates NHE activity in cates that the long-term inhibitory effect of CORTI on
NHE activity occurs only through the cytosolic GR.the rabbit proximal tubule and that this stimulation is
inhibited by COL [35]. Evidence suggests that microtu- Taken together, the long-term inhibitory effect of
CORTI on NHE activity occurs at transcriptional levels.bules also participate in the regulation of other mem-
brane transport processes, including renal H1 pump [53] The present study also demonstrates that the long-
term inhibitory effect of CORTI on NHE activity wasand water channels [54]. Schwartz and Al-Awqati re-
ported that treatment with COL inhibits exocytic inser- prevented by two different PKC inhibitors (ST and
CAL) and by PKC down-regulation with continuous ex-tions of H1 pump into apical membrane of renal proxi-
mal tubular cell [53]. In addition, COL has been shown posure to PMA. These findings suggest that the long-
term CORTI effect, in addition to the short-term CORTIto inhibit the vasopressin-induced insertion of water
channels into apical membrane, consistent with a role for effect, occurs through PKC activation. Similarly, Vrtovs-
nik et al reported in opossum kidney cells that GC inhib-microtubules in the delivery of the vesicles that contain
water channels to the apical membrane [54]. On the its Na1/phosphate cotransport activity through PKC acti-
vation [56]. It is unlikely that PKC down-regulation mayother hand, in VSMCs, the short-term (3 h) stimulatory
effect of aldosterone on NHE activity is inhibited by lead to decreased NHE activity since two PKC inhibi-
tors or PKC down-regulation with continuous exposureboth COL and CYTO [6]. Since COL did not affect basal
NHE activity in control VSMCs (Fig. 8), the data indicate to PMA did not mimic the long-term inhibitory effect
of CORTI on NHE activity (Fig. 7 A–C). The intracellu-that the short-term exposure to CORTI activates a COL-
sensitive process, which activates NHE. However, the lar signaling mechanism responsible for the CORTI-
induced decrease in NHE-1 mRNA abundance has notmechanisms by which CORTI activates NHE via COL-
sensitive process are still unclear. It is possible that NHE been defined in the present study. Nevertheless, the fact
that the decreased NHE activity is dependent on bothprotein may be directly shuttled to the plasma membrane
via microtubules to stimulate NHE activity in CORTI- CORTI-induced PKC activation and gene transcription
suggests that CORTI-induced PKC activation may signaltreated VSMCs. We also propose that an activator of
NHE might be shuttled to the plasma membrane to stim- the decrease in NHE-1 mRNA levels. These results are
in line with the reported effect of 1, 25-dihydroxyvitaminulate silent carriers. For example, PKC has been shown
to rapidly move from a cytoplasmic position to the D3, another steroid hormone on transcriptional regula-
tion of PKC in HL-60 cells [57] and the direct transcrip-plasma membrane following stimulation of cells with
phorbol ester [55]. This possibility is also supported by tional induction by dexamethasone of a serine/threonine
protein kinase gene in cultured cells [58]. However, thethe fact that the short-term stimulatory effect of CORTI
on NHE activity occurs through PKC activation (Fig. 7). mechanisms whereby CORTI may repress transcription
of NHE-1 gene via transcriptional activation of PKC are
Long-term inhibition of NHE activity by CORTI not known.
In sharp contrast to the short-term exposure to
Dual modulation of NHE activity by CORTICORTI, the long-term exposure to CORTI decreased
in VSMCsbasal pHi values, and the CORTI-mediated pHi decrease
is caused by inhibition of NHE activity. Recently, our There are several reports on the time course of NHE
activity [8, 59] and cell growth in GC-treated VSMCslaboratory reported that exposure of VSMCs to aldoste-
rone for 24 hours increased basal values of pHi and that [7–9]. Christ et al have shown that an addition of VSMCs
to hydrocortisone at 10–6 mol/L for four minutes had nothis increase in pHi is a result of increased NHE activity
[6]. Thus, in VSMCs, the long-term effect of CORTI on effect on NHE activity [59]. Berk et al observed that
there was no significant difference in basal- or agonist-NHE activity is opposite to that of aldosterone. Further-
more, the inhibitory effect of CORTI on NHE activity stimulated NHE activity after one or four hours of hydro-
cortisone (1026 mol/L) treatment, but a significant in-was prevented by inhibitors of transcription (ACD) and
of translation (CHX), and was associated with decreased crease in NHE activity occurred 12 hours after treatment
with the hormone, with a maximum increase at 24 hoursNHE-1 mRNA levels. Accordingly, the inhibitory effect
of CORTI is related to a genomic effect. In the present [8]. They also observed that exposure of VSMCs to hy-
drocortisone for 24 hours induces a phenotypic changestudy, long-term exposure to CORTI decreased NHE
activity to 0.6 to 0.7 times the control level, in concor- of VSMCs and inhibits proliferation of cultured rat aortic
VSMCs, if proliferation is induced by 10% fetal calfdance with a decrease in NHE-1 mRNA abundance (0.65
times the control level) by magnitude. These findings serum. Similar growth-inhibiting effects have been re-
ported in bovine aortic smooth muscle cells treated withare consistent with the notion that CORTI inhibits NHE
activity by decreasing NHE-1 mRNA levels. In addition, dexamethasone (1026 mol/L) for five days [7]. However,
the hydrocortisone-induced inhibition of VSMC growthour observation that the long-term effect of CORTI was
inhibited only by the cytosolic GR antagonist (RU) indi- cannot be explained by increased NHE activity, since
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